These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 26300548)

  • 1. The functional relevance of somatic synonymous mutations in melanoma and other cancers.
    Gotea V; Gartner JJ; Qutob N; Elnitski L; Samuels Y
    Pigment Cell Melanoma Res; 2015 Nov; 28(6):673-84. PubMed ID: 26300548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic synonymous mutations in regulatory elements contribute to the genetic aetiology of melanoma.
    Zhang D; Xia J
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):43. PubMed ID: 32241263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma.
    Gartner JJ; Parker SC; Prickett TD; Dutton-Regester K; Stitzel ML; Lin JC; Davis S; Simhadri VL; Jha S; Katagiri N; Gotea V; Teer JK; Wei X; Morken MA; Bhanot UK; ; Chen G; Elnitski LL; Davies MA; Gershenwald JE; Carter H; Karchin R; Robinson W; Robinson S; Rosenberg SA; Collins FS; Parmigiani G; Komar AA; Kimchi-Sarfaty C; Hayward NK; Margulies EH; Samuels Y
    Proc Natl Acad Sci U S A; 2013 Aug; 110(33):13481-6. PubMed ID: 23901115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposing synonymous mutations.
    Hunt RC; Simhadri VL; Iandoli M; Sauna ZE; Kimchi-Sarfaty C
    Trends Genet; 2014 Jul; 30(7):308-21. PubMed ID: 24954581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Screening of Promoter Regions Pinpoints Functional Cis-Regulatory Mutations in a Cutaneous Melanoma Genome.
    Poulos RC; Thoms JA; Shah A; Beck D; Pimanda JE; Wong JW
    Mol Cancer Res; 2015 Aug; 13(8):1218-26. PubMed ID: 26082173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clustered somatic mutations are frequent in transcription factor binding motifs within proximal promoter regions in melanoma and other cutaneous malignancies.
    Colebatch AJ; Di Stefano L; Wong SQ; Hannan RD; Waring PM; Dobrovic A; McArthur GA; Papenfuss AT
    Oncotarget; 2016 Oct; 7(41):66569-66585. PubMed ID: 27611953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reviewing the somatic genetics of melanoma: from current to future analytical approaches.
    Dutton-Regester K; Hayward NK
    Pigment Cell Melanoma Res; 2012 Mar; 25(2):144-54. PubMed ID: 22248438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pan-cancer analysis of synonymous mutations.
    Sharma Y; Miladi M; Dukare S; Boulay K; Caudron-Herger M; Groß M; Backofen R; Diederichs S
    Nat Commun; 2019 Jun; 10(1):2569. PubMed ID: 31189880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetics of melanoma: recent advances.
    Hill VK; Gartner JJ; Samuels Y; Goldstein AM
    Annu Rev Genomics Hum Genet; 2013; 14():257-79. PubMed ID: 23875803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RASopathy Gene Mutations in Melanoma.
    Halaban R; Krauthammer M
    J Invest Dermatol; 2016 Sep; 136(9):1755-1759. PubMed ID: 27236105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin cancer risk in BRCA1/2 mutation carriers.
    Gumaste PV; Penn LA; Cymerman RM; Kirchhoff T; Polsky D; McLellan B
    Br J Dermatol; 2015 Jun; 172(6):1498-1506. PubMed ID: 25524463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjusting for background mutation frequency biases improves the identification of cancer driver genes.
    Evans P; Avey S; Kong Y; Krauthammer M
    IEEE Trans Nanobioscience; 2013 Sep; 12(3):150-7. PubMed ID: 23694700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delving into somatic variation in sporadic melanoma.
    Walia V; Mu EW; Lin JC; Samuels Y
    Pigment Cell Melanoma Res; 2012 Mar; 25(2):155-70. PubMed ID: 22260482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of NTRK1 mutations identified in melanoma.
    Miranda C; Mazzoni M; Sensi M; Pierotti MA; Greco A
    Genes Chromosomes Cancer; 2014 Oct; 53(10):875-80. PubMed ID: 24965840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond the BRAF
    Richtig G; Hoeller C; Kashofer K; Aigelsreiter A; Heinemann A; Kwong LN; Pichler M; Richtig E
    Br J Dermatol; 2017 Oct; 177(4):936-944. PubMed ID: 28278349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of SDHD promoter mutations in various types of melanoma.
    Scholz SL; Horn S; Murali R; Möller I; Sucker A; Sondermann W; Stiller M; Schilling B; Livingstone E; Zimmer L; Reis H; Metz CH; Zeschnigk M; Paschen A; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG
    Oncotarget; 2015 Sep; 6(28):25868-82. PubMed ID: 26327518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple roles of NF1 in the melanocyte lineage.
    Larribère L; Utikal J
    Pigment Cell Melanoma Res; 2016 Jul; 29(4):417-25. PubMed ID: 27155159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic driver mutations in melanoma.
    Reddy BY; Miller DM; Tsao H
    Cancer; 2017 Jun; 123(S11):2104-2117. PubMed ID: 28543693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Somatic Mutations Associated with Metastasis in Acral Melanoma].
    Abramov IS; Emelyanova MA; Ryabaya OO; Krasnov GS; Zasedatelev AS; Nasedkina TV
    Mol Biol (Mosk); 2019; 53(4):648-653. PubMed ID: 31397438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumours associated with BAP1 mutations.
    Murali R; Wiesner T; Scolyer RA
    Pathology; 2013 Feb; 45(2):116-26. PubMed ID: 23277170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.